Treatment of bioprosthetic tissues to mitigate post implantation calcification

• US 6,878,168 B2
• Filed: 01/03/2002
• Issued: 04/12/2005
• Est. Priority Date: 01/03/2002
• Status: Expired due to Term

• Current Assignee: Edwards Lifesciences Corporation
• Original Assignee: Edwards Lifesciences Corporation
• Inventors: Carpentier, Sophie M., Carpentier, Alain F.
• Primary Examiner(s): EINSMANN, MARGARET V
• Application Number:
  US10/039,367
• Publication Number:
  US 20030125813A1
• Time in Patent Office: 1,195 Days
• Field of Search: 8 9/411, 8 9/41.R, 8 9/415, 8 9/42, 600/36, 600/2.13, 600/915, 600/23.72
• US Class Current: 8/94.11
• CPC Class Codes: A61L 2400/02 Treatment of implants to prevent calcification or mineralisation in vivo
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3687 characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
• CPC Class Codes: B65B 63/08 for heating or cooling articles or materials to facilitate packaging

Abstract

Bioprosthetic tissues are treated by immersing or otherwise contacting fixed, unfixed or partially fixed tissue with a glutaraldehyde solution that has previously been heat-treated or pH adjusted prior to its contact with the tissue. The prior heat treating or pH adjustment of the glutaraldehyde solution causes its free aldehyde concentration to decrease by about 25% or more, preferably by as much as 50%, and allows a “stabilized” glutaraldehyde solution to be obtained at the desired concentration and pH for an optimal fixation of the tissue at high or low temperature. This treatment results in a decrease in the tissue'"'"'s propensity to calcify after being implanted within the body of a human or animal patient. The heat-treated or pH adjusted glutaraldehyde solution may, in some cases, also be used as a terminal sterilization solution such that the calcification-decreasing treatment with the previously treated glutaraldehyde and a terminal sterilization may be carried out simultaneously and/or in a single container.

Claims

1. A method for mitigating post-implantation calcification of a bioprosthetic material, said method comprising the steps of:

(a) heating a glutaraldehyde solution having a pH of between 7.2-7.8 to a first temperature above 20°

C. for a first period of time of at least one hour until the pH of the glutaraldehyde solution has been reduced to between 5-7; and

(c) contacting a quantity of biological tissue that contains connective tissue protein with the pH-reduced glutaraldehyde solution for a second period of time of at least one hour.

2. A method according to claim 1, wherein the first temperature is maintained for a period of time until the glutaraldehyde solution further exhibits

a decrease of about 25% or more in the free aldehyde content of the solution.

3. A method according to claim 2 wherein the first temperature is no more than about 90°

C.

4. A method according to claim 2 wherein the first temperature is about 60-80°

C.

5. A method according to claim 2 wherein the first temperature is about 70±

5°

C.

6. A method according to claim 2 further including the step of:

(b) prior to step (c), adjusting the temperature of the glutaraldehyde solution to a second temperature less than the first temperature.

7. A method according to claim 6 wherein the second temperature is about 30-70°

C.

8. A method according to claim 6 wherein the second temperature is about 40-60°

C.

9. A method according to claim 6 wherein the second temperature is about 50±

5°

C.

10. A method according to claim 1 wherein the second temperature is between about 40-60°

C.

11. A method according to claim 1 wherein the tissue is fully fixed prior to the performance of Step (c).

12. A method according to claim 11 wherein the tissue is fixed by immersing the tissue in a solution of glutaraldehyde for 1-14 days.

13. A method according to claim 1 wherein the glutaraldehyde solution in Step (c) is moving relative to the tissue.

14. A method according to claim 1 wherein the method comprises:

preparing a solution of 0.1-25% by weight glutaraldehyde;

heating the glutaraldehyde solution to about 20-90°

C. in Step (a); and

thereafter immersing the tissue in the glutaraldehyde solution in Step (c) while maintaining the temperature of the solution in the range of about 40°

C. to 60°

C. for about 1 day to two months.

15. A method according to claim 14 further comprising the step of subjecting the tissue to a bioburden reduction process.

16. A method according to claim 15 wherein the step of subjecting the tissue to a bioburden reduction process comprises contacting the tissue with a bioburden reduction solution containing a surfactant, an aldehyde and an alcohol.

17. A method according to claim 16 wherein the bioburden reduction solution comprises:

Formaldehyde 2-10% by weight;

Ethanol 10-45% by weight; and

,

Tween 80 (polyoxyethylene (20) sorbitan monooleate) 0.1-10% by weight.

18. A method according to claim 1, wherein the first temperature is maintained for a period of time until the pH of the glutaraldehyde solution has been reduced to 6.0.

19. A method according to claim 18, wherein the pH of the glutaraldehyde solution is initially about 7.4.

20. A method according to claim 1, wherein the first temperature is maintained for a period of time until the pH of the glutaraldehyde solution has been reduced by about 20%.

21. A method according to claim 20, wherein the pH of the glutaraldehyde solution is initially about 7.4.

22. A method according to claim 1 wherein the first period of time is one hour to six months.

23. A method according to claim 22 wherein the first period of time is one day to two months.

24. A method according to claim 22 wherein the first period of time is 1-14 days.

25. A method according to claim 22 wherein the first period of time is 6-8 days.

26. A method according to claim 22 wherein the second period of time is shorter than the first period of time.

27. A method according to claim 22 wherein the second period of time is between 1 to 15 days.

28. A method according to claim 27 wherein the second period of time is between 6 to 8 days.